Retraction Note: A novel polymorphism of the GP78 gene is associated with coronary artery disease in Han population in China
© Cha et al. 2015
Received: 28 May 2015
Accepted: 28 May 2015
Published: 23 July 2015
The original article was published in Lipids in Health and Disease 2014 13:1
This article  has been retracted by the authors due to extensive overlap with previously published work, most notably Zhu et al., Liu et al., and Fu et al. [2–4]. The authors apologise for any inconvenience caused.
- Cha E, Fu Z-Y, Ma Y-T, Zhu Q, Xie X, Liu F. A novel polymorphism of the GP78 gene is associated with coronary artery disease in Han population in China. Lipids Health Dis. 2014;13:147.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhu Q, Fu Z, Ma Y, Yang H, Huang D, Xie X, et al. A novel polymorphism of the CYP2J2 gene is associated with coronary artery disease in Uygur population in China. Clin Biochem. 2013;46(12):1047–54.View ArticlePubMedGoogle Scholar
- Liu T-F, Tang J-J, Li P-S, Shen Y, Li J-G, Miao H-H, et al. Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis. Cell Metab. 2012;16(2):213–25.View ArticlePubMedGoogle Scholar
- Fu Z, Yang H, Ma Y, Huang D, Xie X, Zheng Y, et al. Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China. Gene. 2013;512(2):510–6.View ArticlePubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.